Research suggests that cramp bark's potential muscle-relaxing effects may involve the activation of KCNQ5 potassium channels in vascular smooth muscle, with tannin compounds such as gallic acid and tannic acid identified as likely active constituents responsible for this vasorelaxant activity. This mechanistic explanation comes from a single 2022 laboratory study examining bark extracts from various trees used in Native American traditional medicine, which found mixed relevance for cramp bark specifically, as the closely related Black Haw bark did not activate KCNQ5 or relax blood vessels in the same way. The evidence base is currently limited to preclinical, in vitro research rather than human clinical trials, meaning it is not yet known whether these findings translate to meaningful effects in people. Readers should be aware that one mechanistic laboratory study represents an early stage of scientific inquiry, and more research — including human trials — would be needed to draw firmer conclusions about cramp bark's effectiveness as a muscle relaxant.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| KCNQ5 activation by tannins mediates vasorelaxant effects of barks used in Na... | Other | 2022 | Mixed | 100 |